Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians

Autor: Chun-Bing, Chen, Yi-Hsin, Hsiao, Tony, Wu, Mo-Song, Hsih, Wichittra, Tassaneeyakul, Teekayu P, Jorns, Chonlaphat, Sukasem, Chien-Ning, Hsu, Shih-Chi, Su, Wan-Chun, Chang, Rosaline Chung-Yee, Hui, Chia-Yu, Chu, Yi-Ju, Chen, Ching-Ying, Wu, Chao-Kai, Hsu, Tsu-Man, Chiu, Pei-Lun, Sun, Hua-En, Lee, Chin-Yi, Yang, Pei-Han, Kao, Chih-Hsun, Yang, Hsin-Chun, Ho, Jing-Yi, Lin, Ya-Ching, Chang, Ming-Jing, Chen, Chun-Wei, Lu, Chau Yee, Ng, Kang-Ling, Kuo, Chien-Yio, Lin, Ching-Sheng, Yang, Ding-Ping, Chen, Pi-Yueh, Chang, Tsu-Lan, Wu, Yu-Jr, Lin, Yi-Ching, Weng, Tseng-Tong, Kuo, Shuen-Iu, Hung, Wen-Hung, Chung
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
National Health Programs
0302 clinical medicine
Gene Frequency
Prospective Studies
Prospective cohort study
Child
Aged
80 and over

education.field_of_study
Incidence (epidemiology)
Incidence
Middle Aged
Thailand
Carbamazepine
Child
Preschool

Anticonvulsants
Female
Adult
medicine.medical_specialty
Adolescent
Genotype
Population
Taiwan
Oxcarbazepine
Statistics
Nonparametric

03 medical and health sciences
Young Adult
Asian People
Meta-Analysis as Topic
Internal medicine
medicine
Humans
Genetic Predisposition to Disease
education
Aged
Retrospective Studies
Epilepsy
HLA-A Antigens
business.industry
Retrospective cohort study
Odds ratio
medicine.disease
Confidence interval
Toxic epidermal necrolysis
030104 developmental biology
HLA-B Antigens
Relative risk
Stevens-Johnson Syndrome
Neurology (clinical)
business
030217 neurology & neurosurgery
Zdroj: Neurology. 88(1)
ISSN: 1526-632X
Popis: Objective:To investigate the risk and genetic association of oxcarbazepine-induced cutaneous adverse reactions (OXC-cADRs), including Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), in Asian populations (Chinese and Thai).Methods:We prospectively enrolled patients with OXC-cADRs in Taiwan and Thailand from 2006 to 2014, and analyzed the clinical course, latent period, drug dosage, organ involvement, complications, and mortality. We also investigated the carrier rate ofHLA-B*15:02andHLA-A*31:01of patients with OXC-cADRs and compared to OXC-tolerant controls. The incidence of OXC-SJS/TEN was compared with carbamazepine (CBZ)–induced SJS/TEN according to the nationwide population dataset from the Taiwan National Health Insurance Research Database.Results:We enrolled 50 patients with OXC-cADRs, including 20 OXC-SJS/TEN and 6 drug reaction with eosinophilia and systemic symptoms, of Chinese patients from Taiwan and Thai patients from Thailand. OXC-cADRs presented with less clinical severity including limited skin detachment (all ≦5%) and no mortality. There was a significant association betweenHLA-B*15:02and OXC-SJS (p= 1.87 × 10−10; odds ratio 27.90; 95% confidence interval [CI] 7.84–99.23) in Chinese and this significant association was also observed in Thai patients. The positive and negative predictive values ofHLA-B*15:02for OXC-SJS/TEN were 0.73% and 99.97%, respectively.HLA-A*31:01was not associated with OXC-cADRs. The incidence and mortality of OXC-SJS/TEN was lower than CBZ-STS/TEN in new users (p= 0.003; relative risk 0.212; 95% CI 0.077–0.584).Conclusions:Our findings suggest thatHLA-B*15:02is significantly associated with OXC-SJS in Asian populations (Chinese and Thai). However, the severity and incidence of OXC-SJS/TEN are less than that of CBZ-SJS/TEN. The need for preemptiveHLA-B*15:02screening should be evaluated further.
Databáze: OpenAIRE